Published in

Future Medicine, Biomarkers in Medicine, 18(13), p. 1577-1588, 2019

DOI: 10.2217/bmm-2019-0124

Links

Tools

Export citation

Search in Google Scholar

Interleukins and miRNAs intervene in the early stages of diabetic kidney disease in Type 2 diabetes mellitus patients

Journal article published in 2019 by Ligia Petrica ORCID, Oana Milas, Mihaela Vlad, Adrian Vlad, Florica Gadalean, Victor Dumitrascu, Silvia Velciov, Cristina Gluhovschi, Flaviu Bob, Sorin Ursoniu, Dragos C. Jianu, Petru Matusz, Agneta-Maria Pusztai, Octavian Cretu, Daniela Radu and other authors.
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Green circle
Postprint: archiving allowed
Upload
Green circle
Published version: archiving allowed
Upload
Policy details
Data provided by SHERPA/RoMEO

Abstract

Aim: The involvement of proinflammatory interleukins (IL) in diabetic kidney disease of Type 2 diabetes mellitus (DM) patients was studied in relation to a particular miRNA profile. Materials & methods: A total of 117 patients with Type 2 DM and 11 controls were enrolled in a case series study. Serum and urinary ILs and miRNAs were assessed. Results: IL-1α correlated with miRNA21, 124, estimated glomerular filtration rate (eGFR) and negatively with miRNA125a and 192; IL-8 with miRNA21, 124, eGFR and negatively with miRNA125a, 126 and 146a; IL-18 with miRNA21, 124 and negatively with miRNA146a, 192, eGFR. Conclusion: There is an association between specific serum and urinary ILs and serum and urinary miRNAs profiles in the inflammatory response in Type 2 DM patients with diabetic kidney disease.